Imeik Technology Development Co Ltd
SZSE:300896
Imeik Technology Development Co Ltd
SZSE:300896
Price:
113.33
CNY
-3.14%
Market Cap:
¥34.3B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Imeik Technology Development Co Ltd
SZSE:300896
|
CN |
|
Lumos Pharma Inc
NASDAQ:LUMO
|
US |
|
UOB-Kay Hian Holdings Ltd
SGX:U10
|
SG |
|
Digital Bros SpA
MIL:DIB
|
IT |
|
Wise Group AB
STO:WISE
|
SE |
|
City Pub Group PLC
LSE:CPC
|
UK |
|
N
|
Nice Ltd
TASE:NICE
|
IL |
Multiples-Based Value
The Multiples-Based Value of one
Imeik Technology Development Co Ltd
stock under the Base Case scenario is
hidden
CNY.
Compared to the current market price of 113.33 CNY,
Imeik Technology Development Co Ltd
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Imeik Technology Development Co Ltd Multiples-Based Value
LOCKED
Multiples Across Competitors
Competitors Multiples
Imeik Technology Development Co Ltd Competitors
Imeik Technology Development Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
|
Imeik Technology Development Co Ltd
SZSE:300896
|
34.3B CNY | 14 | 26.6 | 22.3 | 22.3 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
375.5B USD | 6.1 | 89.7 | 14.8 | 20.6 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
191.7B USD | 5.2 | 24.8 | 14.4 | 14.4 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
176.3B USD | 6 | 20.7 | 12.9 | 16 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
113.5B USD | 9.5 | 28.7 | 21.6 | 22.5 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
81.2B USD | 5.7 | 18 | 13.5 | 15.4 | |
| NL |
|
argenx SE
XBRU:ARGX
|
41.9B EUR | 11.8 | 37.9 | 40.9 | 41.8 | |
| AU |
|
CSL Ltd
ASX:CSL
|
67.6B AUD | 3 | 33 | 11.1 | 13.9 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
